StonvexLoading…
StonvexStonvexStonvexCore line items from HDSN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $60.15M | $246.61M | $202.20M | $128.19M |
Operating Income | $1.46M | $18.56M | $29.77M | $15.80M |
Net Income | $330.00K | $16.67M | $25.30M | $12.93M |
EPS (Diluted) | $0.01 | $0.37 | $0.56 | $0.28 |
Total Assets | $308.92M | $318.65M | $338.95M | $317.85M |
Total Liabilities | $71.25M | $75.26M | $73.06M | $63.07M |
Cash & Equivalents | $19.37M | $39.46M | $89.68M | $84.29M |
Free Cash Flow OCF − CapEx | $-13.88M | $-8.21M | $25.44M | $18.69M |
Shares Outstanding | 42.05M | 41.65M | 43.60M | 43.65M |